← Back to patent-cliff list
盐酸噻氯匹定/银杏叶提取物
Tier C — Watch / tradeTiclopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract
株式会社柳柳
Originator
2008
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：P2RY12
Brand：Yuclid
Indications (approved)：动脉闭塞性疾病、脑血管疾病、栓塞和血栓形成
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract?
Approved indications include: 动脉闭塞性疾病, 脑血管疾病, 栓塞和血栓形成.
When does the Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract patent expire?
No public expiry year is available for Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract yet; this page updates once verified.
How do I get a quote for Ticlopidine Hydrochloride/Ginkgo Biloba Leaf Dried Extract intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24